|
|
42
|
B4624
|
SYNJARDY 12.5MG|1G (BOE) EMPAGLIFLOZIN|METFORMIN
|
60'S
|
A
|
1.12
|
12.5MG|1G
|
60
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
41
|
B4625
|
DAPAGLIFLOZIN|METFORMIN 10MG|1G TAB (KWA)
|
30'S
|
A
|
0.3325
|
10MG|1G
|
30
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
42
|
B462D
|
DAPAGLIFLOZIN|METFORMIN 10MG|1G XR TAB (ZHL)
|
3X10
|
A
|
0.27
|
10MG|1G
|
30
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
40
|
B4811
|
VYMADA 24MG | 26MG TAB (NVS/COL) SACUBITRIL | VALSARTAN
|
28'S
|
B
|
2.52
|
24MG|26MG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
6
|
|
|
41
|
B4811
|
VYMADA 24MG|26MG TAB (NVS) SACUBITRIL|VALSARTAN (B)
|
28'S
|
B
|
2.33
|
24MG|26MG
|
60
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
42
|
B4811
|
VYMADA 24MG|26MG TAB (NVS) SACUBITRIL|VALSARTAN
|
28'S
|
B
|
1.75
|
24MG|26MG
|
60
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
40
|
B4812
|
VYMADA 49MG | 51MG TAB (NVS/COL) SACUBITRIL | VALSARTAN
|
28'S
|
B
|
2.52
|
49MG|51MG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
6
|
|
|
41
|
B4812
|
VYMADA 49MG|51MG TAB (NVS) SACUBITRIL|VALSARTAN (B)
|
28'S
|
B
|
2.33
|
49MG|51MG
|
60
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
42
|
B4812
|
VYMADA 49MG|51MG TAB (NVS) SACUBITRIL|VALSARTAN
|
28'S
|
B
|
1.75
|
49MG|51MG
|
60
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
40
|
B4813
|
VYMADA 97MG | 103MG TAB (NVS/COL) SACUBITRIL | VALSARTAN
|
28'S
|
B
|
2.52
|
97MG|103MG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
6
|
|
|
41
|
B4813
|
VYMADA 97MG|103MG TAB (NVS) SACUBITRIL|VALSARTAN (B)
|
28'S
|
B
|
2.33
|
97MG|103MG
|
60
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
42
|
B4813
|
VYMADA 97MG|103MG TAB (NVS) SACUBITRIL|VALSARTAN
|
28'S
|
B
|
1.75
|
97MG|103MG
|
60
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
40
|
B4911
|
XOLAIR 150MG INJ (NVS/COL) OMALIZUMAB
|
150MG VIAL
|
C
|
1,304.93
|
150MG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
B4911
|
XOLAIR 150MG INJ (NVS) OMALIZUMAB (C)
|
150MG VIAL
|
C
|
1304.9314
|
150MG
|
0
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
|
42
|
B4911
|
XOLAIR 150MG INJ (NVS) OMALIZUMAB
|
150MG VIAL
|
C
|
1,304.93
|
150MG
|
0
|
2026-04-01
|
|
No
|
No
|
|
0
|
|
|
40
|
B4913
|
OMALIREL 150MG INJ (RLS/AHI) OMALIZUMAB
|
150MG VIAL
|
C
|
844.86
|
150MG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
B4913
|
OMALIREL 150MG INJ (RLS) OMALIZUMAB (C)
|
150MG VIAL
|
C
|
844.8551
|
150MG
|
0
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
|
42
|
B4913
|
OMALIREL 150MG INJ (RLS) OMALIZUMAB
|
150MG VIAL
|
BQ
|
747.54
|
150MG
|
0
|
2026-04-01
|
|
No
|
No
|
|
0
|
|
|
40
|
B5012
|
ANORO ELLIPTA 55/22 INHR (GSK/COL) UMECLIDINI
|
30 DOSES
|
BQ
|
141.60
|
55MCG|22MCG
|
1
|
2022-04-01
|
2024-03-31
|
|
|
|
6
|
|
|
41
|
B5012
|
ANORO ELLIPTA 55MCG|22MCG INHR (GSK) UMECLIDINIUM|VILANTEROL (BQ)
|
30 DOSES
|
BQ
|
108.6786
|
55MCG|22MCG
|
1
|
2024-04-01
|
2024-07-16
|
|
Yes
|
|
6
|
